stoxline Quote Chart Rank Option Currency Glossary
  
Sintx Technologies, Inc. (SINT)
3.74  0.203 (5.74%)    12-26 16:00
Open: 3.67
High: 3.74
Volume: 37,129
  
Pre. Close: 3.537
Low: 3.4925
Market Cap: 10(M)
Technical analysis
2025-12-26 4:42:01 PM
Short term     
Mid term     
Targets 6-month :  4.62 1-year :  5.2
Resists First :  3.95 Second :  4.46
Pivot price 3.75
Supports First :  3.15 Second :  2.62
MAs MA(5) :  3.62 MA(20) :  3.73
MA(100) :  3.78 MA(250) :  0
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  20.6 D(3) :  22.7
RSI RSI(14): 51.9
52-week High :  7.36 Low :  1.71
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SINT ] has closed above bottom band by 48.5%. Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.74 - 3.76 3.76 - 3.78
Low: 3.45 - 3.47 3.47 - 3.49
Close: 3.71 - 3.74 3.74 - 3.77
Company Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Headline News

Mon, 08 Dec 2025
SINTX Technologies to Participate in Sidoti & Company Investor Conference - Yahoo Finance

Mon, 08 Dec 2025
Ascendiant Capital Maintains Sintx Technologies (SINT) Buy Recommendation - Nasdaq

Mon, 01 Dec 2025
Sintx Technologies, Inc. Signs Supply Agreement with Evonik Corporation - TradingView — Track All Markets

Mon, 01 Dec 2025
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants - Ortho Spine News

Tue, 21 Oct 2025
Insider Buying: Eric Olson Acquires Additional Shares of SINTX T - GuruFocus

Thu, 16 Oct 2025
$30B Antipathogenic Market: SINTX USPTO Notice of Allowance for Method Patent Broadens Licensing - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 4 (M)
Held by Insiders 2.99e+006 (%)
Held by Institutions 17 (%)
Shares Short 254 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -9.26e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 601.9 %
Return on Equity (ttm) -53.1 %
Qtrly Rev. Growth 1.27e+006 %
Gross Profit (p.s.) -117.47
Sales Per Share -323.88
EBITDA (p.s.) 1.04921e+006
Qtrly Earnings Growth -3.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 2.1
Stock Dividends
Dividend 0
Forward Dividend 223230
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android